<unk>  can cause allergic reactions, conjunctivitis, and keratitis and, due to its immunosuppressive effects, reactivation of cold sores. In clinical trials, people receiving<unk>  had decreased levels of T helper cells. There is one reported case of<unk>  triggering hair growth in a patient with complete hair loss. This is being investigated as an unintended, but positive, side effect. One other case reports a possibility of chronic eosinophilic pneumonia associated with<unk> . Some concern of potential worsened COVID-19 disease with patients taking<unk>  have been expressed, but according to one study all patients had mild course of disease.
Dupilumab
Olaratumab
Emapalumab
Ustekinumab
Evolocumab
Burosumab
Sarilumab
Evinacumab